@dr_morepen
#API Formulations HomeHealth

Api - loratadine,Atorvastatin,Montelukast,Fexofenadine,Rosuvastatin,Sitagliptin,Olmesartan,Voglibose,Dapagliflozin,Vildagliptin etc

Formulations - antibiotics,GI,CNS,Ortho,Calcium,Respiratory,Antiallergic,Nutraceuticals
#pharma #Nifty
Devices - BP monitor,Glucometer,Pulse oximeter,Thermometer

Mcap - 1320
CMP - 29.4
P/E 19.3
BV 7.36
FV 2
ROCE 10.2
OPM 8.97
D/E 0.05
EVEBIDTA 12.2
EPS 0.75
Int coverage 40.8
@dr_morepen investor presentation Q2fy21
Q2 fy20/Q2fy21 in crs
Revenue 216/340,up 57%
Ebidta 17.8/35.4,up 99%
PAT 4.08/27.17 ,up 566%
EPS 0.09/0.6,up 566%

3 verticals
Bulk drugs(#API ) - antidiabetics,antihypertensive,antivirals,anticancer,neuropsychologica
#Morepen
Diagnostic devices - glucometer, BP monitor, nebulizers,weighing scale,digital & IR thermometers, Oximeters,O2 concentrators

Finished dosages - prescription drugs mfg ,distribution, contract mfg
Manufacturing facilities
Baddi (HP) - APIs, R&D,OTC,Formulations, Diagnostic devices
Masulkhana(HP) - APIs,R&D
Parwanoo (HP) - Formulations

Revenues % Formulations 12,devices 25,API 63

Q2fy20/21 In crs
API 116/185
Diag devices 45/90
OTC 15/23
Formulations 34.7/33.4
#stocks
API growth in crs
2019 413
2020 473
1st half 21 347
Domestic 31,Exports 69
72% exports to regulated mkts - US,EU,APAC
Export revenue up 37%
Q2fy20/Q2fy21
92.4/127.56

Intellectual property - 125 patents,111 DMFs,9 China-IDLs,25 new products
#Morepen #Nifty #sensex
API expansion project under PLI scheme
Project cost 178 crs
Capacity 2000MT
New hiring 700 people
Time 3 yrs

Mkt size of #morepen products in API $4bn,go down next 5 yrs to $2.825bn,old drugs patent expired last 19 yrs
New launches addressable mkt at $35bn,expiry of patent 5yrs
Diagnostic devices
Q2fy20/21 in crs
45.52 /90.35
Glucometer contributes 71% of gross revenue in fy19-20
Q2fy21 0.408 mn glucometers & 60 million strips sold

Finished dosage rev down 4% affected by covid,recovery QoQ
Q2fy20/21 34.7/33.43

OTC
Fy20/21 15/ 23
Fy20/H121 64/44
Q2FY20/21
EPS 0.09/0.6
REV 216/340
Ebidta 17.8 /35.4
PAT 4.08 /27.17

Mar 20/ Sep 20
ROE 11.8/ 14.1%
Reserve 194/241

Unroll
@threadreaderapp
Compile
@threader_app

#Nifty #sensex #StockMarket #stocks #Markets

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with TheMarket🐝

TheMarket🐝 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @BullsforBears

28 Nov
@GranulesIndia earnings call transcript Q2fy21
No longer a 5 product company
22 launched products
PAT growth up 80% H1fy21 compared to H1fy20,due to fast approval of filed ANDAs,rapid scale up production
Ebidta,PAT > Rev growth- better product mix,sales,op efficiency
#Stocks
32 approved ANDAs(6 yet to launch),13 waiting for approval
Expect 1 MUPS tech based ANDA in Q3 or Q4
Construction MUPS block on track,commercialize Q3fy22
High vol MUPS products & APIs next major driver
Q1fy21 recall of $2 mn tabs Metformin 750mg,this Q 1mn reversed into books
Covid expense 19.3 crs in H1fy21
Rev Q1fy20/21 858/700 cr up23% yoy
Gross margin moved 48.6 to 57.9% YoY thru new launches,increased finished dosages,product rationalization in PFI & Finished dosages
PAT 164 vs 96 crs,up 71% yoy
#Stocks #pharma #Nifty #sensex
Read 9 tweets
27 Nov
#PLISCHEME #GOI
Approves for 10 sectors On Nov 11
Pharma,Auto,Auto components Telecom,Advanced chemistry cell battery,textile,food products,solar modules,white goods,speciality steel

Aim - make India mfts globally competitive,enhance scale,increase exports,attract investment
Pli scheme aimed to reduce dependence on China,give incentive on products mftd in India, increase employment by focusing on labor intensive industries like mobile equipment,#pharma,medical devices
In March #goi made 53 drugs eligible for pli worth 6940cr ,benefit 136 mftg units
14000 cr package incentivise #API production & medical devices mfg
3240 cr to promote medical devices mft
Pli for electronics & mobiles,incentives of 4-6% to mft mobiles & other electrical components such as transistors,diodes,resistors etc
#Telecom #mobile #Nifty #sensex
Read 10 tweets
22 Nov
#CAMS Concall highlights Q2fy21
CAMS serviced assets now at ~70% industry assets
Key properties - myCAMS,GoCorp,edge360
UPI Autopay mech offered by CAMSPay enabled for SIP investors
2Q industry Aum 27.6 trillion, up 7% you, 12% wow,equity assets were muted
#Nifty #sensex
CAMS serviced funds & assets at 19.4 trillion or 19.4 lakh crore, up 8.6% yoy, up 11% qoq ,share at 70%
Outflow in equity assets,mainly lump category,investors timing the market taking money out
Majority growth non equity,mainly debt,liquid fund flattish,overall equity contractd
Overall transaction volumes 79 mlln plus,5 % up QoQ
SIP book,expanded 5% yoy,1% qoq
Live investors folios up 4% yoy about 40 mlln
Unique serviced investors expanded to 16.2 mn,6% yoy growth
H1fy21 AUM muted at 26.1 trillion, 2% up yoy, equity down 5.2%
Read 10 tweets
21 Nov
@PolycabIndia investor presentation Q2fy21
Top line revenue 21137 mn
-6% YoY, up 116% QoQ
H1fy21 : 30903 mn, -26%you

Ebidta Q2fy21 3122 mn
Up 16% YoY,up 454% QoQ
H1fy21 3685 mn,-25% YoY

PAT Q2fy21 2216 mn
Up 14% yoy ,up 88% wow
H1fy21 3391 mn,up 3% yoy
#investing #Nifty
Net cash position Q2fy21 6276 mn,up 82% yoy ,up 205% qoq
Revenue declined 6% yoy in Q2 vs 50 % decline in Q1
Ebidta up 16% yoy with 272 bps yoy improvement account of higher contribution & cost saving initiatives
PBT & PAT up 25% & 14% yoy
ROCE 26.6% ,Net cash 6.3bn
#StockMarket
Revenue declined 26% yoy due to severe covid impact & subsequent lockdown in Q1
PAT in H1fy21 exceed last year aided by one off gains

Wires & cables
Q2fy20 / Q1fy21 / Q2fy21 in mn INR
Revenue 18811/7935/ 17408
Ebit 2011/ 243/ 2534
H1fy21
Revenue 34916 / 25343
Ebit 3873 / 2778
Read 8 tweets
21 Nov
@NATCOPharmaLtd concall Q2fy21
Increase in other expenditure due to covid related employee expenses,increments,litigation issues & setting up REMS about 3 to 4 products

Approval received for Pomalyst,Eugia & Natco both got approvals,$ 1bn sales,also settled related litigation
Weak domestic sales due to drop in Hepatitis C sales , covid caused less patients to seek cancer Rx

Good build in Tamiflu sales,1st to get into Brazil,received govt orders from Canada ,profit share recognized after sales confirmed by Alvogen,benefits to accrue in Q3,Q4
Launched a portfolio of products in Agrochemicals
Chemo sales 70-75% of normal
Cardio & diabetology sales done well
One time expense setting up REMS for Revlimid
REMS setting up takes $ 2 to 3 mn cost upfront
As of Sep'20 cash equivalents is 1065 cr & debt 431 crs
#Nifty
Read 6 tweets
20 Nov
After months of use ,billions of $ for pharma companies
Oxygen,steroids,and heparin,glucose control,early diagnosis & treatment mainstay
@Cipla_Global
#gilead
WHO suspends Remdesivir from list of medicines timesofindia.indiatimes.com/world/europe/w…
Download the TOI app now:
timesofindia.onelink.me/mjFd/toisupers…
@USFDA & @WHO appear to take different paths
Barcitinab approved for use with #remdesivir for #COVID19 infection
#API
#cdmo #pharma #Nifty #sensex #stocks
expresspharma.in/covid19-update…
Mild to mod cases with early treatment
Early diagnosis & treatment holds the key

#dontletdownthatmaskyet
#COVID19
#LongCovid
#Nifty
#stocks
City docs find proof Favipiravir works for the moderately ill
toi.in/ZJsSBa14/
Download the TOI app now:
timesofindia.onelink.me/mjFd/toisupers…
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!